Baxter International Reaches New 52-Week High (BAX)

Baxter International (NYSE:BAX) hit a new 52-week high Thursday as it is currently trading at $73.97, above its previous 52-week high of $73.95 with 1.1 million shares traded as of 11:45 a.m. ET. Average volume has been 3.4 million shares over the past 30 days.
By TheStreet Wire ,

NEW YORK (

TheStreet

) --

Baxter International

(NYSE:

BAX

) hit a new 52-week high Thursday as it is currently trading at $73.97, above its previous 52-week high of $73.95 with 1.1 million shares traded as of 11:45 a.m. ET. Average volume has been 3.4 million shares over the past 30 days.

Baxter International has a market cap of $39.47 billion and is part of the health care sector and health services industry. Shares are up 9.6% year to date as of the close of trading on Wednesday.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates

Baxter International

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full

Baxter International Ratings Report

.

See all

52-week high stocks

or get investment ideas from our

investment research center

.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

.

null

Loading ...